Affymetrix CytoScan Dx Assay for postnatal detection of DNA CNVs

Wednesday, 16 April, 2014 | Supplied by: Millennium Science Pty Ltd



The Affymetrix CytoScan Dx Assay is intended for the postnatal detection of DNA copy number variants (CNV) in patients referred for chromosomal testing. It is designed to help physicians diagnose children’s developmental and intellectual disabilities more comprehensively by enabling a high-resolution genome-wide analysis of genetic aberrations.

The product analyses the whole genome in a single assay at very good resolution, improving diagnostic capability. High-resolution analysis can reveal small aberrations not readily seen using traditional techniques.

The company’s For Research Use Only version of the assay is currently available in Australia for both constitutional and cancer cytogenetics research applications.

Online: www.mscience.com.au
Phone: 03 8561 9000
Related Products

Thermo Fisher Scientific Applied Biosystems SeqStudio Genetic Analyzer for Human Identification

Forensic scientists now have access to the Applied Biosystems SeqStudio Genetic Analyzer for...

siTOOLs Biotech riboPOOLs

Ribosomal RNA depletion pools (riboPOOLs) by siTOOLs Biotech provide a flexible solution for rRNA...

InSite L. mono Glo swab test for Listeria

InSite L. mono Glo is a self-contained swab system for the simultaneous detection of...


  • All content Copyright © 2019 Westwick-Farrow Pty Ltd